Development of an oral formulation for ICAM-1 antisense oligonucleotides

Transplantation Proceedings

Volumn 33, Issue 1-2, 2001, Pages 387-

  Stepkowski, S M ^a,c   Chen, W ^a   Geary, R ^b   Wang, M E ^a   Condon, T ^b   Stecker, K ^b   Bennett, C F ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b ISIS PHARMACEUTICALS   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE;

CONFERENCE PAPER; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; GRAFT SURVIVAL; KIDNEY ALLOGRAFT REJECTION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; INTERCELLULAR ADHESION MOLECULE-1; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, INBRED ACI; RATS, INBRED LEW;

EID: 0035077679     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)02798-6     Document Type: Conference Paper

References (3)

1. Stepkowski SM, Wang ME, Condon TP, et al: Transplantation 66:699, 1998
2. Fisher B, Lee S: Surgery 58:904, 1965
3. Levin AA, Monteith DK, Leeds JM, et al: In Crooke ST (ed): Antisense Research Applications. Berlin: Springer-Verlag; 1998, p 169